Novo Nordisk's reports to the FDA spiked shortly after an inspection found the Ozempic producer ignored reports of deaths and potential side effects.

New research challenges fears about Ozempic weight regain. Cleveland Clinic study of 8,000 patients finds minimal rebound ...

The former NBA All-Star has lost near 100 pounds in recent years.

Researchers found that the odds of developing an eye condition that leads to vision loss were about 5 times higher among ...

(Competitive Insight/Unsplash) While GLP-1 drugs such as Wegovy and Ozempic are now being broadly championed and widely used, ...

Stopping popular weight-loss injections like Ozempic or Mounjaro might not trigger the dramatic rebound many fear. A large real-world study of nearly 8,000 patients found that most people who ...

(Javier Zayas Photography/Moment/Getty Images) A new analysis suggests that people who stop taking Ozempic-like medications ...

People who quit taking popular GLP-1 drugs such as Ozempic might their jeopardize heart health, according to a new study.

The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the green light this weekend to start selling generic versions of Ozempic and Wegovy, with several ...

The appearance of stars at the Oscars 2026 has sparked debate over Hollywood’s growing reliance on Ozempic and other GLP-1 ...

The problem is that at about age 30, adults already begin losing muscle at about 3-5%  every 10 years, according to the ...